Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Receivables: 2017-2019

Historic Receivables for Cogent Biosciences (COGT) over the last 2 years, with Dec 2019 value amounting to $2.0 million.

  • Cogent Biosciences' Receivables rose 19.90% to $2.0 million in Q4 2019 from the same period last year, while for Dec 2019 it was $6.4 million, marking a year-over-year increase of 8.86%. This contributed to the annual value of $2.0 million for FY2019, which is 19.90% up from last year.
  • Per Cogent Biosciences' latest filing, its Receivables stood at $2.0 million for Q4 2019, which was up 127.27% from $880,000 recorded in Q3 2019.
  • Cogent Biosciences' 5-year Receivables high stood at $2.0 million for Q1 2019, and its period low was $830,000 during Q4 2017.
  • In the last 3 years, Cogent Biosciences' Receivables had a median value of $1.5 million in 2019 and averaged $1.5 million.
  • As far as peak fluctuations go, Cogent Biosciences' Receivables skyrocketed by 100.96% in 2018, and later plummeted by 37.98% in 2019.
  • Over the past 3 years, Cogent Biosciences' Receivables (Quarterly) stood at $830,000 in 2017, then surged by 100.96% to $1.7 million in 2018, then rose by 19.90% to $2.0 million in 2019.
  • Its last three reported values are $2.0 million in Q4 2019, $880,000 for Q3 2019, and $1.5 million during Q2 2019.